Cuba began development of its health biotechnology sector by imitating products developed elsewhere, such as interferon-α 2b (IFN-α), but in recent years greater emphasis has been placed on ...

Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and ...

Discover Danaher's impressive financial performance, low risk, and growth potential driven by strategic investments in ...

The growth metrics depict a pessimistic decline in ICON's revenues and EBITDA for this year. However, in the last five years, ...

If you’re on the hunt for the latest scoop on Betechit Tech News: Unlock Incredible Innovations Changing Tomorrow, you’ve landed at the right spot. This ...

Redtree Venture Capital is a firm that helps companies grow. They put money into businesses that are ready to expand. This ...

We’re excited about supporting Valmet Flow Control in their PLM journey.” Fulvisol, an Aras Gold Partner, is collaborating with Valmet Flow Control to support the implementation of Aras Innovator.

Two biotech innovators launched products that solve challenges in gene therapy scale-up and learn from omics data from ...

Industry leader brings 25+ years of experience in therapeutic development and precision medicine to advance company's neurodegenerative disease programs SAN DIEGO, CA, UNITED STATES, June 3, 2025 ...

Out of 51 applications received by the FDA Orphan Products Grants Program in fiscal year 2024, Palvella's Phase 3 Selva trial was one of only seven new clinical trials selected for funding—and ...

See the latest Bio-Techne Corp stock price (TECH:XNAS), related news, valuation, dividends and more to help you make your investing decisions.